These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5069461)

  • 1. [Therapeutic trial with azo-Wintomylon in acute urinary infections].
    Cadena G; Garrocho C
    Prensa Med Mex; 1972; 37(5):228-31. PubMed ID: 5069461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advantage of azocline in the treatment of urinary infections].
    Olmer M; Salvadori JM
    Mars Med; 1970; 107(1):71-80. PubMed ID: 5419924
    [No Abstract]   [Full Text] [Related]  

  • 3. [A drug combination in the treatment of urinary infection].
    Azevedo JR
    Matern Infanc (Sao Paulo); 1966; 25(4):681-6. PubMed ID: 5997368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and bacteriological testing of a combination of a new antibiotic and an azo dye in urology].
    Schulman CC; Hallemans E
    Schweiz Rundsch Med Prax; 1970 Aug; 59(31):1136-7. PubMed ID: 5510300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experimentation of a new antibiotic-azo dye combination (N4,N4-terephthalal-bis-[D-4-amino-3-isooxazolidone] + 2,6-diamino-3-phenylazo-pyridine hydrochloride) in urinary tract infections].
    Zini S; Marcelli G
    Minerva Urol; 1965; 17(5):206-8. PubMed ID: 5323623
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic and toxicologic problems in the therapy of nonspecific urinary tract infections with impaired kidney function].
    Haschek H; Porpáczy P
    Wien Klin Wochenschr; 1968 Oct; 80(42):769-76. PubMed ID: 5710482
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of chronic urinary tract infections].
    Haschek H
    Med Welt; 1972 Oct; 23(42):1473-5. PubMed ID: 4636868
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of Wintomylon in urinary infections. Observations on 50 patients].
    Ferreira AA
    Hospital (Rio J); 1966 Nov; 70(5):1313-7. PubMed ID: 5301946
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of Ro 4-4309 (uro-gantanol) in infection of the kidney and urinary tract].
    Vergison R; Casselman J
    Acta Urol Belg; 1967 Jul; 35(3):465-75. PubMed ID: 5615605
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lower urinary tract infections in women: a comparison between nalidixic acid and trimethoprim-sulfadiazine].
    Falk G; Eriksson M; Fellner H
    Lakartidningen; 1981 Sep; 78(40):3474-6. PubMed ID: 7321693
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of Mictral with co-trimoxazole in the treatment of urinary tract infections.
    Healey JC
    Practitioner; 1982 Nov; 226(1373):1971-4. PubMed ID: 6760166
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical use of Wintomylon (nalidixic acid) in the field of urology].
    Gotoh K; Shinoda T; Ito S; Isogai K; Kimura T; Ohtani F; Ishiyama K
    Hinyokika Kiyo; 1965 Oct; 11(10):1011-4. PubMed ID: 5324357
    [No Abstract]   [Full Text] [Related]  

  • 13. [Initial therapy in acute urinary tract infection].
    Weilacher JS
    Z Allgemeinmed; 1972 Jan; 48(2):68-70. PubMed ID: 4550903
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of Wintomylon (nalidixic acid) in the urinary tract infections].
    Yamasaki I; Kato T; Ogawa T
    Hinyokika Kiyo; 1965 Sep; 11(9):913-34. PubMed ID: 5324475
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience with the use of oxolinic acid (Gramurin) and nalidixic acid (Nevigramon)].
    Kelenhegyi M; Szabó Z; Soltész I; Varga A
    Orv Hetil; 1978 Sep; 119(37):2267-9. PubMed ID: 358051
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of urinary tract infections].
    Borsa F; Humbert G
    Rev Prat; 1985 Mar; 35(15):843-51. PubMed ID: 3159070
    [No Abstract]   [Full Text] [Related]  

  • 17. [Azocline treatment of urinary infections caused by common germs, in a present-day urological practice].
    Archimbaud JP; Moine C
    Lyon Med; 1968 Nov; 220(46):1297-306. PubMed ID: 5757909
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug-resistant organisms in urinary tract infections and clinical use of Wintomylon (nalidixic acid)].
    Kuze M; Kashiwagi T; Okita J; Komiya T; Nihira H
    Hinyokika Kiyo; 1966 Mar; 12(3):291-6. PubMed ID: 6006673
    [No Abstract]   [Full Text] [Related]  

  • 19. [Norfloxacin sensitivity of bacterial pathogens of urinary tract infections].
    Modde H
    Schweiz Rundsch Med Prax; 1985 Apr; 74(17):439-42. PubMed ID: 3159064
    [No Abstract]   [Full Text] [Related]  

  • 20. [A clinical evaluation of Wintomylon in the treatment of urinary infections].
    Inada T; Ebisuta K; Kitayama T; Miyakawa M
    Hinyokika Kiyo; 1966 Oct; 12(10):1150-5. PubMed ID: 6008094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.